Tower View Wealth Management’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-42,490	Closed	-$5M	–	183
2022 Q1	$5M	Buy	42,490 +463	+1%	+$51.9K	2.69%	7
2021 Q4	$5.45M	Buy	42,027 +163	+0.4%	+$19K	2.77%	6
2021 Q3	$4.74M	Sell	41,864 -105	-0.3%	-$12K	2.63%	6
2021 Q2	$4.35M	Sell	41,969 -81	-0.2%	-$7.63K	2.2%	15
2021 Q1	$3.52M	Buy	42,050 +363	+0.9%	+$30.7K	1.92%	21
2020 Q4	$3.8M	Buy	41,687 +1,559	+4%	+$129K	2.16%	17
2020 Q3	$3.2M	Buy	40,128 +210	+0.5%	+$16.4K	2.09%	19
2020 Q2	$2.76M	Buy	39,918 +786	+2%	+$55.9K	2.02%	22
2020 Q1	$2.46M	Buy	39,132 +465	+1%	+$33.5K	2.22%	19
2019 Q4	$3.01M	Sell	38,667 -1,485	-4%	-$116K	2.28%	14
2019 Q3	$2.94M	Buy	40,152 +15	+0%	+$1.05K	2.43%	11
2019 Q2	$2.47M	Sell	40,137 -690	-2%	-$41.7K	2.11%	20
2019 Q1	$2.6M	Sell	40,827 -885	-2%	-$50.5K	2.31%	16
2018 Q4	$2.13M	Buy	41,712 +414	+1%	+$20.9K	2.2%	19
2018 Q3	$2.4M	Sell	41,298 -9,798	-19%	-$479K	2.1%	16
2018 Q2	$2.48M	Buy	51,096 +240	+0.5%	+$11.2K	2.34%	10
2018 Q1	$2.37M	Sell	50,856 -4,950	-9%	-$215K	2.36%	11
2017 Q4	$2.1M	Buy	+55,806	New	+$2.05M	1.93%	17